Skip to main content

Table 1 Demographics of the study cohort

From: FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients

 

Whole cohort

Female cohort (n = 97)

Male cohort (n = 103)

 
 

Median or Mean ± SD

IQR

Median or Mean ± SD

IQR

Median or Mean ± SD

IQR

p (female vs male)

Age

53.3 ± 12.7

 

55.0 ± 12.4

 

51.8 ± 12.8

 

0.08

BMI

28.0 ± 5.3

 

27.5 ± 4.9

 

28.4 ± 5.7

 

0.42

FVC

98.4

83.2–108.4

98.7

84.7–106.3

98.3

83.3–109.8

0.91

TLC

86.3

75.1–95.8

85.0

74.3–95.9

87.5

75.3–95.0

0.50

DLCOsb

80.2

69.9–90.9

80.4

71.3–89.4

78.8

67.9–91.2

0.80

FEV1

85.8

74.5–99.1

86.8

75.6–98.7

84.6

74.4–99.1

0.64

GHS

67.9

51.9–80.2

69.8

58.0–81.1

64.2

49.1–79.3

0.15

GHS L

73.0

56.7–82.2

74.2

59.1–84.0

68.0

53.4–80.9

0.28

GHS E

69.4

54.4–80.6

71.7

57.8–82.1

68.3

50.0–80.6

0.30

GHS S

72.1

60.0–83.6

75.4

63.6–85.0

67.9

55.7–80.7

0.06

GHS LS

73.1

59.7–83.7

77.4

62.3–85.4

70.8

50.8–81.6

0.15

GHS LM

72.5

59.2–82.0

76.8

62.2–83.2

69.4

54.6–81.9

0.14

GHS SM

72.3

61.6–82.7

76.3

67.6–84.4

68.8

57.8–79.2

0.02

GHS LSM

74.3

60.7–83.3

78.4

64.7–84.5

71.8

58.4–80.0

0.06

LUNG

77.8

58.3–93.1

76.4

58.3–93.1

77.8

58.3–93.1

0.88

MED

84.9

54.6–100

84.9

67.7–100

77.3

54.6–100

0.13

SKIN

88.2

70.6–100

94.1

70.6–100

82.4

70.6–100

0.15

EYES

77.0

52.7–93.2

77.0

53.4–93.2

73.0

52.7–93.2

0.63

Borg

0.5

0.0–2.0

0.5

0.0–2.0

0.5

0.0–2.8

0.50

sIL2R

513.5

380–713

506.5

378.8–679.5

528.5

380–735

0.59

Neopterin

11.5

8.4–16.4

12.2

9.0–16.3

10.3

7.7–16.5

0.09

ACE

35.4

22.7–48.9

39.1

25.6–51.2

28.8

20.6–43.8

0.06

  1. Italics indicate values with borderline significance defined as 0.05
  2. Values with statistical significance defined as p < 0.05 were indicated in bold